The estimated Net Worth of Dan Stokely is at least $420 Thousand dollars as of 25 June 2021. Mr Stokely owns over 22,500 units of Ampio Pharmaceuticals Inc stock worth over $112 and over the last 5 years he sold AMPE stock worth over $0. In addition, he makes $419,495 as CFO and Corp. Sec. & Treasurer at Ampio Pharmaceuticals Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr CPA AMPE stock SEC Form 4 insiders trading
Mr has made over 4 trades of the Ampio Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 22,500 units of AMPE stock worth $9,675 on 25 June 2021.
The largest trade he's ever made was exercising 52,500 units of Ampio Pharmaceuticals Inc stock on 12 February 2021 worth over $133,875. On average, Mr trades about 13,636 units every 12 days since 2019. As of 25 June 2021 he still owns at least 50,815 units of Ampio Pharmaceuticals Inc stock.
You can see the complete history of Mr Stokely stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Daniel G. Stokely CPA, CPA biography
Daniel G. Stokely CPA, CPA is the CFO, Corp. Sec. & Treasurer at Ampio Pharmaceuticals Inc.
What is the salary of Mr CPA?
As the CFO and Corp. Sec. & Treasurer of Ampio Pharmaceuticals Inc, the total compensation of Mr CPA at Ampio Pharmaceuticals Inc is $419,495. There are 1 executives at Ampio Pharmaceuticals Inc getting paid more, with Michael E. Macaluso having the highest compensation of $457,040.
How old is Mr CPA?
Mr CPA is 57, he's been the CFO and Corp. Sec. & Treasurer of Ampio Pharmaceuticals Inc since . There are 8 older and 3 younger executives at Ampio Pharmaceuticals Inc. The oldest executive at Ampio Pharmaceuticals Inc is Philip Coelho, 75, who is the Independent Director.
What's Mr CPA's mailing address?
Dan's mailing address filed with the SEC is C/O AMPIO PHARMACEUTICALS, INC., 373 INVERNESS PARKWAY, SUITE 200, ENGLEWOOD, CO, 80112.
Insiders trading at Ampio Pharmaceuticals Inc
Over the last 13 years, insiders at Ampio Pharmaceuticals Inc have traded over $202,762 worth of Ampio Pharmaceuticals Inc stock and bought 377,748 units worth $116,063 . The most active insiders traders include Philip H Coelho, Joshua R. Disbrow, and J Kevin Buchi. On average, Ampio Pharmaceuticals Inc executives and independent directors trade stock every 192 days with the average trade being worth of $74. The most recent stock trade was executed by J Kevin Buchi on 9 June 2023, trading 21,858 units of AMPE stock currently worth $6,339.
What does Ampio Pharmaceuticals Inc do?
ampio pharmaceuticals inc (ampe) is a biotechnology company located in 5445 dtc pkwy, greenwood village, colorado, united states.
What does Ampio Pharmaceuticals Inc's logo look like?
Complete history of Mr Stokely stock trades at Ampio Pharmaceuticals Inc
Ampio Pharmaceuticals Inc executives and stock owners
Ampio Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Michael E. Macaluso,
Founder, Chairman & CEO (Leave of Absence ) -
Daniel G. Stokely CPA, CPA,
CFO, Corp. Sec. & Treasurer -
Holli Cherevka,
Chief Operating Officer -
Daniel Stokely,
Chief Financial Officer, Treasurer, Secretary -
Michael Macaluso,
Chairman of the Board, Chief Executive Officer -
Holli Cherevka,
Pres & COO -
David Bar-Or,
Director -
David Stevens,
Independent Director -
Richard Giles,
Independent Director -
Philip Coelho,
Independent Director -
Laura Goldberg,
VP of Quality and Regulatory Operations -
April Ramirez,
Clinical Trial Mang. -
Lane Hapke,
VP of Manufacturing Operations -
Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D.,
Chief Medical Officer -
Michael A. Martino,
CEO & Chairman -
Michael A Martino,
CEO -
J Kevin Buchi,
Director -
Vaughan Lennox Clift,
Chief Regulatory Affairs -
Gregory A Gould,
Chief Financial Officer -
Iii Thomas E. Chilcott,,
Chief Financial Officer -
Dan Stokely,
CFO -
Mark D Mc Gregor,
Chief Financial Officer -
Joshua R. Disbrow,
Chief Operating Officer -
Elizabeth Varki Jobes,